These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 9345066

  • 1. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K, McKenna HJ, Charrier K, Morrissey PJ, Williams DE, Lyman SD.
    Blood; 1997 Nov 01; 90(9):3781-8. PubMed ID: 9345066
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
    Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M.
    Blood; 1997 May 01; 89(9):3186-91. PubMed ID: 9129021
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
    Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J.
    Blood; 1993 Apr 01; 81(7):1709-19. PubMed ID: 7681699
    [Abstract] [Full Text] [Related]

  • 4. Synergy of growth factors during mobilization of peripheral blood precursor cells with recombinant human Flt3-ligand and granulocyte colony-stimulating factor in rabbits.
    Pless M, Wodnar-Filipowicz A, John L, Baldomero H, Lyman SD, Nissen C, Gratwohl A.
    Exp Hematol; 1999 Jan 01; 27(1):155-61. PubMed ID: 9923454
    [Abstract] [Full Text] [Related]

  • 5. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.
    Neipp M, Zorina T, Domenick MA, Exner BG, Ildstad ST.
    Blood; 1998 Nov 01; 92(9):3177-88. PubMed ID: 9787154
    [Abstract] [Full Text] [Related]

  • 6. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential.
    Molineux G, McCrea C, Yan XQ, Kerzic P, McNiece I.
    Blood; 1997 Jun 01; 89(11):3998-4004. PubMed ID: 9166838
    [Abstract] [Full Text] [Related]

  • 7. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.
    Grzegorzewski KJ, Komschlies KL, Franco JL, Ruscetti FW, Keller JR, Wiltrout RH.
    Blood; 1996 Dec 01; 88(11):4139-48. PubMed ID: 8943848
    [Abstract] [Full Text] [Related]

  • 8. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C, Di Nicola M, Magni M, Longoni P, Milanesi M, Stucchi C, Cleris L, Formelli F, Gianni MA.
    Cancer Res; 2002 Nov 01; 62(21):6152-7. PubMed ID: 12414641
    [Abstract] [Full Text] [Related]

  • 9. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.
    Exp Hematol; 1999 Mar 01; 27(3):416-24. PubMed ID: 10089903
    [Abstract] [Full Text] [Related]

  • 10. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M, Pelosi E, Montesoro E, Valtieri M, Luchetti L, Samoggia P, Vitelli L, Barberi T, Testa U, Lyman S.
    Blood; 1995 Sep 01; 86(5):1661-70. PubMed ID: 7544638
    [Abstract] [Full Text] [Related]

  • 11. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ, Farese AM, Davis TA, Lind LB, McKearn JP.
    Exp Hematol; 1999 Oct 01; 27(10):1557-68. PubMed ID: 10517498
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination.
    Robinson S, Mosley RL, Parajuli P, Pisarev V, Sublet J, Ulrich A, Talmadge J.
    J Hematother Stem Cell Res; 2000 Oct 01; 9(5):711-20. PubMed ID: 11091495
    [Abstract] [Full Text] [Related]

  • 13. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET, Towery JA, Miller AN, Kramer C, Hogan KR, Squires JE, Stuart RK, Costa LJ.
    Transfusion; 2011 Sep 01; 51(9):1995-2000. PubMed ID: 21392017
    [Abstract] [Full Text] [Related]

  • 14. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
    Benboubker L, Cartron G, Roingeard F, Delain M, Degenne M, Linassier C, Hérault O, Truglio D, Bout M, Petit A, Brémond JL, Desbois I, Colombat P, Binet C, Domenech J.
    Exp Hematol; 2003 Jan 01; 31(1):89-97. PubMed ID: 12543111
    [Abstract] [Full Text] [Related]

  • 15. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 01; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 16. In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor.
    Papayannopoulou T, Nakamoto B, Andrews RG, Lyman SD, Lee MY.
    Blood; 1997 Jul 15; 90(2):620-9. PubMed ID: 9226162
    [Abstract] [Full Text] [Related]

  • 17. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 18. Hematologic effects of flt3 ligand in vivo in mice.
    Brasel K, McKenna HJ, Morrissey PJ, Charrier K, Morris AE, Lee CC, Williams DE, Lyman SD.
    Blood; 1996 Sep 15; 88(6):2004-12. PubMed ID: 8822919
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA.
    Bone Marrow Transplant; 1994 Dec 15; 14(6):877-84. PubMed ID: 7536069
    [Abstract] [Full Text] [Related]

  • 20. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON, Gerson SL, Cooper BW, Laughlin M, Meyerson H, Kutteh L, Fox RM, Szekely EM, Tainer N, Lazarus HM.
    J Clin Oncol; 2000 May 15; 18(9):1824-30. PubMed ID: 10784622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.